CDSCO Clarifies Regulatory Pathway for Globally Unapproved New Drugs After Phase III Global Clinical Trials
CDSCO clarification 10 August 2026, globally unapproved new drugs India, Form CT-18, NDCT Rules 2019, Phase III Global Clinical Trial…
Read More